Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 31

Results For "Lupin"

351 News Found

Lupin launches generic version of Brovana in US
News | June 04, 2021

Lupin launches generic version of Brovana in US

Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction


Lupin to foray into the digital healthcare space
Digitisation | June 03, 2021

Lupin to foray into the digital healthcare space

The company recently incorporated a new entity in the name of Lupin Digital Health Limited


Lupin announces U.S. FDA acceptance for pegfilgrastim biosimilar application
News | June 03, 2021

Lupin announces U.S. FDA acceptance for pegfilgrastim biosimilar application

Pegfilgrastim has estimated annual sales of USD 3.66 billion in the U.S. (IQVIA MAT December 2020).


Lupin receives US $50 mn on achieving cancer milestone
News | May 28, 2021

Lupin receives US $50 mn on achieving cancer milestone

MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination


Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr
News | May 13, 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021


Lupin enters into agreement with Lilly to expand access for COVID-19
News | May 10, 2021

Lupin enters into agreement with Lilly to expand access for COVID-19

Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.


LupinLife to promote hand hygiene at Kumbh Mela 2021
News | March 24, 2021

LupinLife to promote hand hygiene at Kumbh Mela 2021

Lupin will provide five lakh LupiSafe hand sanitizers to policemen and frontline workers deployed at strategic locations


Lupin launches authorized generic version of Alinia
News | March 13, 2021

Lupin launches authorized generic version of Alinia

Nitazoxanide Tablets, 500 mg (RLD: Alinia) had estimated annual sales of USD 56 million in the U.S.


Lupin Pharma Canada announces Partnership with Endoceutics
News | March 09, 2021

Lupin Pharma Canada announces Partnership with Endoceutics

Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.


Lupin launches penicillamine tablets USP
News | March 04, 2021

Lupin launches penicillamine tablets USP

Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).